Drugs / DEN1-80E
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00936429 | Jul 2009 → Jul 2010 | dengue disease | Hawaii Biotech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DEN1-80E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00936429 ↗ |
| Modality | Vaccine | “A monovalent version of the vaccine candidate, DEN1-80E” PMID 26458804 ↗ Oct 2015 |
| Route | Intramuscular | “3 doses of DEN1-80E vaccine administered as 0.5 ml intramuscularly in deltoid.” NCT00936429 ↗ |